Fagron to acquire CareFirst and Injeplast.

Fagron, a pharmaceutical company, agreed to acquire CareFirst, a provider of compounding pharmacy services, and Injeplast, a manufacturer of compounded medicines. Financial terms were not disclosed. “We are incredibly pleased to announce these two acquisitions, which reflect our disciplined and strategic growth approach. The acquisition of CareFirst allows us to meet the increasing demand in the prevention and lifestyle segments, reinforcing our leadership in North America. Similarly, the addition of Injeplast will strengthen our market positioning in Latin America by broadening our product portfolio and expanding our customer base. Both businesses align with Fagron’s Group margin, and we expect to integrate them over the next 18 to 24 months,” Rafael Padilla, Fagron CEO.